Anil Kumar, J. et al. Generation of FMDV recombinant 3ABC protein and development of monoclonal antibodies as reagents for 3ABC quantitative ELISA. Current Trends in Biotechnology and Pharmacy Vol. 13 (1) 7-19 (2019)
Anil Kumar, J. et al. Purification of Foot and mouth disease virus non-structural protein 3ABC from vaccine in- process samples and their characterization. Current Trends in Biotechnology and Pharmacy Vol. 12 (4) 334-341 (2018).
Sridevi, N. V. et al. Development of anti-bovine IgA single chain variable fragment and its application in diagnosis of foot-and-mouth disease. Eur. J. Microbiol. Immunol. 4(1), 34–44 (2014).
Madhanmohan M. et al. Transmission of Foot-and-mouth disease virus from experimentally infected Indian buffalo (Bubalus bubalis) to in-contact naïve and vaccinated Indian buffalo and cattle. Vaccine 31, 5125-5130 (2014).
Abhinay, G. et al. A novel site -II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use. Vaccine 32, 209-213 (2014).
Yuvaraj, S. et al. Genetic and antigenic characterization of Indian foot-and-mouth disease virus serotype O isolates collected during the period 2001 to 2012. Infect. Genet. Evol. 13, 109-115 (2013).
Yuvaraj, S. et al. A single amino acid deletion in capsid protein VP1 G-H loop region of a serotype O foot and mouth disease virus isolate from India. Curr. Trends Biotechnol. Pharm. 7(2), 597-602 (2013).
Yuvaraj, S. et al. Selection of foot and mouth disease virus candidate vaccine strain for serotype O. Curr. Trends Biotechnol. Pharm. 7(1), 550-555 (2013).
Gangadhararao A. et al. Ante-mortem and post-mortem examinations of the cattle calf naturally infected with Mycobacterium avium subsp. Paratuberculosis. Eur. J. Microbiol. Immunol 3 (4), 241-251 (2013).
Madhanmohan, M. et al. Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid serotyping of foot-and-mouth disease virus. J. Virol. Methods 187(1), 195-202 (2013).
Bhavani V. J. et al. Determination of threshold stimulation index for IGRAs using ESAT-6 and CFP-10 antigens for bovine TB diagnostics in India. Int. J. Pharm Bio Sci. 3(4), 740-749 (2012).
Mohana, S. B. et al. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency. Antiviral Res. 96(3), 288-295 (2012).
Madhanmohan, M. et al. Clinical protection, sub-clinical infection and persistence following vaccination with extinction payloads of O1 Manisa Foot-and-Mouth disease monovalent vaccine and challenge in goats and comparison with sheep. Res. Vet. Sci. 93(2), 1050-1059 (2012).
Sathish, K. et al. Oral immunization of birds against recombinant Eimera antigens: An approach for vaccinating poultry birds against coccidiosis. Curr. Trends Biotechnol. Pharm. 6(3), 312-321 (2012).
Naidu, H. et al. Typing of canine parvovirus isolates using mini-sequencing based single nucleotide polymorphism analysis. J. Virol. Methods 181 (2), 197-201 (2012).
Sathish, K. et al. Plant expressed coccidial antigens as potential vaccine candidates in protecting chicken against coccidiosis. Vaccine 30(30), 4460-4464 (2012).
Trangadia, B. J. et al. Serological investigation of bovine brucellosis, Johne’s disease and infectious bovine rhinotracheitis in two states of India. J. Adv. Vet. Res. 2(1), 38-41 (2012).
Trangadia, B. J. et al. Evaluation of fluorescence polarization assay for the diagnosis of brucellosis in cattle and buffaloes in India. Ind. J. Anm. Sci. 82(6), 561-564 (2012).
Veerasami, M. et al. Multi-antigen print immunoassay for seroepidemiological surveillance of bovine tuberculosis on Indian cattle farms. Vet. Ital. 48(3), 253-267 (2012).
Veerasami, M. et al. Foot and Mouth Disease (FMD) in Indian buffaloes. M. Veerasami, B. Pattnaik and Srinivasan V.A. FAO – ICAR International Conference (2012) .
Dev Chandran and V.V.Srinivasan.FMD vaccine production and quality control in India. Indian Farming 61(11): 13-6 (2012).
Mythili, T. et al. A Brucella abortus S19 Glyco-conjugate Vaccine Consisting of Lipopolysaccharide and outer Membrane Protein Protects Mice against Challenge with Brucella abortus. Journal of Advanced Veterinary Research Volume 2: 99-106 (2012).
D Chandran, Srinivasan V. A. Animals vaccines - poised for a great leap. Cutting Edge (2012).
Parthasarathy, S. et al. Use of ESAT-6-CFP-10 fusion protein in the bovine interferon-gamma ELISPOT assay for diagnosis of Mycobacterium bovis infection in cattle. J. Microbiol. Methods 90(3), 298-304 (2012).
Human
Praveen, A. et. al. Diphtheria: An overview of diagnosis and therapeutic Applications. Current Trends in Biotechnology and Pharmacy Vol. 13 (1) 72-82 (2019)
Praveen, A. et. al. Development of Murine monoclonal antibodies, characterization and quantification of Diphtheria toxoid in vaccine batches. Current Trends in Biotechnology and Pharmacy Vol. 12 (4) 318-333 (2018).
Aavula , S.M. et al. A novel in vitro ELISA for estimation of glycoprotein content in human rabies vaccines. J Immunoassay Immunochem. 2017; 38(4):400-410 (2017).
Shahana, P. V. et al. Efficient production of Tymovirus like particles displaying immunodominant epitopes of Japanese Encephalitis Virus envelope protein. Protein Expr. Purif. 113, 35-43 (2015).
Verma, R. R. et al. Seroprevalence of Antibodies to HPV L1 in a limited population study determined by the GST-Capture ELISA. Curr. Trends Biotechnol. Pharm. 9(2), 97- 106 (2015).
Ravi Ranjan Verma, et al. Comparison of the Efficacies of Different ELISA formats in Sero-detection of Antibodies to HPV 16 E7 Oncoprotein. Current Trends in Biotechnology and Pharmacy Vol. 9 (3) 97-106 (2015).
Neelakantam, B. et al. Identification and Characterization of Novel Binding Epitope of Tetanus toxoid by Phage Display Peptide Library. Curr. Trends Biotechnol. Pharm. 9 (1), 49-58 (2015).
Shukra, A. et al. Production of Recombinant Antibodies using Bacteriophages. Eur. J. Microbiol. Immunol. 4 (2), 91–98 (2014).
Neelakantam, B. et al. Recombinant human antibody fragment against tetanus toxoid produced by phage display. Eur. J. Microbiol. Immunol. 4 (1), 45–55 (2014).
Ramya, R. et al. Assessment of packed bed bioreactor systems in the production of viral vaccines. AMB Express 4, 25 (2014).
Vidyasagar, P. et al. Generation and characterization of neutralizing monoclonal antibodies against baculo-expressed HPV 16 VLPs. Eur. J. Microbiol. Immunol. 4(1), 56-64 (2014).
Shahana, P.V. et al. Japanese Encephalitis: An overview of vaccine development. Curr. Trends Biotechnol. Pharm. 8 (3), 303-308 (2014).
Rajendar, B. et al. A simple and rapid method to monitor the disassembly and reassembly of virus-like particles. Anal. Biochem. 440(1), 15–17 (2013).
Shahana, P.V. et al. Enhancement of Japanese Encephalitis Virus DNA vaccine efficacy by using Mycobacterium avium paratuberculosis heat shock protein 65. Curr. Trends Biotechnol. Pharm. 7(4), 904-913 (2013).
Verma, R. R. et al. E6 protein of Human Papillomavirus 16 (HPV16) expressed in Escherichia coli sans a stretch of hydrophobic amino acids, enables purification of GST-ΔE6 in the soluble form and retains the binding ability to p53. Protein Expr. Purif. 92(1), 41-47 (2013).
Ramya, R. et al. Immuno-affinity purification of insect cell expressed rabies virus glycoprotein using a conformational specific monoclonal antibody. J. Adv. Vet. Res. 2(4), 232-238 (2012).
Nimmagadda, S. V. et al. Development of recombinant single-chain variable fragment against hepatitis A virus and its use in quantification of hepatitis A antigen. Biologicals 40(4), 299-308 (2012).
Ponnanna, N. M. et al. Construction of a vector for the constitutive expression of Human Papillomavirus type 16 genes in Salmonella enterica serovar Typhi strain Ty21a. Curr. Trends Biotechnol. Pharm. 6(3), 373-380 (2012).
Ponnanna, N. M. et al. T cell response to oncoprotein E7 of Human Papillomavirus genotype 16 (HPV 16) delivered by Salmonella typhi strain Ty21a (S. typhi Ty21a) in mice. Curr. Trends Biotechnol. Pharm. 6(4), 398-406 (2012).
